Navigation Links
$30 Million CABG Market Supported by Use of Intuitive Surgical's da Vinci Robot in Minimally Invasive CABG Procedures
Date:12/2/2010

TORONTO, Dec. 2, 2010 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, cardiac surgeons are trying new innovative approaches to traditional open heart surgery as they try to make coronary artery bypass graft (CABG) procedures less invasive where possible.

Developments in CABG techniques have led to the introduction of less invasive variations of CABG surgery. Minimally invasive direct coronary artery bypass, for example, involves making a small incision between the ribs in order to access the heart. Instead of creating the necessary 10 to 12 inch incision to separate the sternum, minimally invasive direct coronary artery bypass keeps the sternum intact and only requires a 3 to 5 inch incision.  

Totally endoscopic coronary artery bypass is another minimally invasive variation of CABG that makes use of Intuitive Surgical's da Vinci robot.  The da Vinci can be used during CABG procedures by inserting robotic instruments through small incisions made in between the patient's ribs. The robotic instruments are able to provide the physician with a 3D internal image, which has been magnified 10 times and mimics the hand movements of the physician at the controls. While the advantages of totally endoscopic coronary artery bypass, including reduced patient recovery time and greater postoperative patient comfort, are similar to those that result from minimally invasive direct coronary artery bypass procedures, the use of a robot allows for the procedure to be performed with greater ease.

"Minimally invasive direct coronary artery bypass procedures are not appropriate for all patients though," says Julie McLaughlin, Analyst at MRG. "They only allow physicians to reach a limited number of coronary arteries, therefore limiting the procedure to patients who require only one or two vessel bypasses. These patients can often be treated with stents, and physi cians who perform minimally invasive direct coronary artery bypass procedures have indicated that they are performing fewer procedures than in previous years due to increased treatment of eligible minimally invasive direct coronary artery bypass patients with stents. The procedure is also technically more difficult to learn and perform compared to alternatives.  For this reason it is not anticipated that many physicians will start performing minimally invasive direct coronary artery bypass procedures over the next five years."

MRG's US Markets for Coronary Artery Bypass Graft Devices 2011 report includes analysis on on-pump coronary artery bypass devices, off-pump coronary artery bypass devices, endoscopic vessel harvesting devices, and anastomosis assist devices.

About Millennium Research GroupMillennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Amy KrohnMillennium Research Group416-364-7776 ext. 101akrohn@mrg.netChris ComfortDecision Resources, Inc. 781-993-2597ccomfort@dresources.com
'/>"/>

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Globus Medical Raises $110 Million in Series E Financing Round
2. Atritech Announces Completion of a $22 Million Equity Financing
3. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
4. EntreMed Raises $20 Million to Support Clinical Development Program
5. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
6. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
7. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
8. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
9. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
10. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
11. 38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2017)... INDIANAPOLIS , June 10, 2017  Eli Lilly and ... results from three Phase 3 studies of galcanezumab, an ... migraine, including late-breaking data on several key secondary endpoints ... Detailed results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) ... (AHS) annual scientific meeting in Boston ...
(Date:6/9/2017)... INDIANAPOLIS , June 9, 2017 ... In a further effort to help spread lessons learned ... condition, the International Diabetes Federation (IDF) and Eli Lilly ... together for the second phase of the Bringing Research ... 2), reaffirming their commitment to helping people with diabetes ...
(Date:6/8/2017)... , June 8, 2017  StatLab Medical ... developer and manufacturer of diagnostic supplies for ... that Cressey & Company LP ("Cressey & ... completed a growth-focused investment in the Company. ... ownership position from selling shareholder, Prairie Capital, ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... 28, 2017 , ... Hayes, Inc., a leading provider of ... speaker lineup* for its second annual Client Symposium. Joining the symposium this year ... Fernandez of Privia Health; and Lisa Tourville of Anthem. , “We are ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the ... the award winning television series, scheduled to broadcast fourth quarter 2017. American Farmer airs ... a regional supplier of garden pea seed. As demand grew, the small company located ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... and financial consultations to communities in northern Virginia and DC, is announcing a ... provide for patients with Alzheimer’s and other disorders that lead to memory impairment. ...
(Date:6/27/2017)... ... June 27, 2017 , ... Harbour , a DAO (decentralized ... the Ethereum blockchain, has released their technical specifications . , 2017 has seen ... little systematic approach for determining which offerings will garner the greatest ROI. Dean Eigenmann, ...
(Date:6/27/2017)... Beverly Hills, California (PRWEB) , ... June 27, 2017 , ... ... implants market has been projected to reach a staggering $6.81 billion by the year ... implants are rising at a faster rate than those made from titanium. Los Angeles ...
Breaking Medicine News(10 mins):